PRACTICA OTO-RHINO-LARYNGOLOGICA
Vol. 101 No. 8 August 2008
Clinical Analysis of Parotid Carcinoma
Hajime Ishinaga, Shinobu Arima, Atsushi Yuta,
Kazuhiko Takeuchi and Yuichi Majima
(Mie University Graduate School of Medicine)
Parotid carcinoma is relatively rare in head and neck cancer, and its treatment is still controversial because of its diverse histology.
A total of 37 cases of parotid carcinoma were treated in our hospital between 1991 and 2005. In terms of the therapeutic strategy, patients with low-grade carcinoma were treated by surgery alone with preservation of the facial nerves, whereas those with high-grade carcinoma underwent surgery with facial nerve resection and full-dose radiotherapy.
We performed neck dissection in only N+ patients. The 5-year, cause-specific survival rate in the 37 patients with parotid carcinoma was 67.5%, being 76.0% for those with low-grade cancer and 58.0% for those with high-grade cancer. Our study suggests that more extensive surgery is required for those with high-grade malignancy in order to improve the 5-year survival rate.
Key words :parotid carcinoma, low-grade carcinoma, high-grade carcinoma